Organometallics
Article
1
NMR (101 MHz, THF-d8): δ (ppm) 175.3 (C2), 125.7 (C4), 120.1
(C5), 70.8 (cod-CH), 70.4 (cod-CH), 64.8 (cod-CH), 59.6 (cod-
CH), 35.5 (s, C6), 33.3 (cod-CH2), 33.0 (cod-CH2), 32.7 (cod-
CH2), 32.6 (cod-CH2). HRMS (ESI, positive ions) m/z: 763.2086
[[2] + H]+ (calcd for [[2] + H]+ 763.2097).
a red solid. Yield: 64 mg (of the complex mixture). H NMR (400
MHz, THF-d8, only resonances for the main component [6] are
listed): δ (ppm) 7.39 (s, 1H, H5), 6.81 (s, 1H, H8), 5.13−5.02 (m,
1H, cod-CH), 4.46−4.40 (m, 1H, cod-CH), 4.02−3.92 (m, 2H, cod-
CH), 3.78 (s, 3H, H12), 2.89−2.80 (m, 1H, cod-CH2), 2.64−2.54
(m, 2H, cod-CH2), 2.50−2.42 (m, 1H, cod-CH2), 2.27 (s, 3H, H11),
2.21 (s, 3H, H10), 2.19−2.14 (m, 2H, cod-CH2), 2.07−2.01 (m, 1H,
cod-CH2), 2.00−1.93 (m, 1H, cod-CH2). 13C{1H} NMR (101 MHz,
THF-d8, only resonances for the main component [6] are listed): δ
(ppm) 188.1 (s, C2), 143.4 (s, C4), 137.1 (s, C9), 128.7 (s, C6),
4.3.2. Characterization of Complex [3]. Complex [3] was
1
obtained as an orange solid. Yield: 12 mg, 0.205 mmol (41%). H
NMR (400 MHz, THF-d8): δ (ppm) 6.70 (d, 3JHH = 1.1 Hz, 1H, H4),
6.57 (d, 3JHH = 1.1 Hz, 1H, H5), 4.51−4.45 (m, 1H, cod-CH), 4.28−
4.17 (m, 2H, cod-CH), 3.83−3.75 (m, 1H, cod-CH), 3.63 (s, 3H,
H6) 2.69−2.63 (m, 1H, cod-CH2), 2.59−2.51 (m, 2H, cod-CH2),
2.46−2.40 (m, 1H, cod-CH2), 2.21−2.13 (m, 2H, cod-CH2), 1.95−
1.85 (m, 2H, cod-CH2). 13C{1H} NMR (101 MHz, THF-d8): δ
1
128.2 (s, C7), 115.6 (s, C5), 109.9 (s, C8), 78.9 (d, JCRh = 3.9 Hz,
1
cod-CH), 78.7 (d, JCRh = 2.6 Hz), 73.6 (s, cod-CH), 72.0 (s, cod-
CH), 33.24 (s, cod-CH2), 33.22 (s, C12), 32.8 (s, cod-CH2), 32.3 (s,
cod-CH2), 32.0 (s, cod-CH2), 20.5 (s C11), 20.2 (s, C10). HRMS
(ESI, positive ions) m/z: 830.2405 [6]+ (calcd for [6]+ 830.2409).
4.6. Synthesis of Complex [7]. Compound 1 (16 mg, 0.10
mmol) was dissolved in THF (5 mL) and the solution was cooled to
−78 °C. Then, n-BuLi (0.13 mmol, 0.08 mL of a 1.6 M solution in n-
hexane) was added. The reaction mixture was stirred for 2 h at −78
°C. Then, [Ir(cod)(μ-Cl)]2 (16.8 mg, 0.025 mmol) was added and
the solution was stirred over night while it was allowed to warm up to
ambient temperature. The solvent was removed in vacuo and the solid
residue was dissolved in THF (2 mL). Addition of n-pentane led to
precipitation of a white solid. The suspension was filtered through
Celite and the solvent was removed from the filtrate under reduced
pressure to give complex [7] as a reddish solid. Yield: 23 mg, 0.037
1
(ppm) 180.6 (d, JCRh = 50.5 Hz, C2), 127.1 (s, C4), 119.1 (s, C5),
1
1
85.5 (d, JCRh = 7.7 Hz, cod-CH), 83.6 (d, JCR1h = 8.4 Hz, cod-CH),
1
80.4 (d, JCRh = 13.2 Hz, cod-CH), 77.0 (d, JCRh = 11.4 Hz, cod-
CH), 35.6 (s, C6), 32.4 (s, cod-CH2), 32.2 (s, cod-CH2), 31.9 (s,
cod-CH2), 31.8 (s, cod-CH2). HRMS (ESI, positive ions) m/z:
584.0518 [3]+ (calcd for [3]+ 584.0894).
4.4. General Procedure for the Synthesis of Complexes [4]
and [5]. Compound 1 (32.0 mg, 0.20 mmol) was dissolved in THF
(5 mL) and the solution was cooled to −78 °C. Then, n-BuLi (0.2
mmol, 0.13 mL of a 1.6 M solution in n-hexane) was added. The
reaction mixture was stirred for 2 h at −78 °C. Subsequently,
[Ir(cod)(μ-Cl)]2 (0.1 mmol, 67.2 mg) or [Rh(cod)(μ-Cl)]2 (0.10
mmol, 49.3 mg) was added and the solution was stirred for 12 h while
it was allowed to warm up to ambient temperature. The solvent was
removed in vacuo and the resulting residue was washed with
methanol (2 × 5 mL) and dried under reduced pressure.
4.4.1. Characterization of Complex [4]. Complex [4] was
obtained as a red solid. Yield: 41 mg, 45 mmol, 45%. 1H NMR
(400 MHz, THF-d8): δ (ppm) 7.40 (s, 1H, H5), 6.85 (s, 1H, H8),
4.82 (s br, 1H, cod-CH), 4.43 (s br, 1H, cod-CH), 3.85 (s br, 1H,
cod-CH), 3.80 (s, 3H, H12), 3.58 (s br, 1H, cod-CH), 2.68−2.60 (m,
1H, cod-CH2), 2.49−2.41 (m, 2H, cod-CH2), 2.36 (s, 1H, cod-CH2),
2.25 (s, 3H, H11), 2.22 (s, 3H, H10), 2.20−2.18 (m, 1H, cod-CH2),
2.15−2.13 (m, 1H, cod-CH2), 1.80−1.76 (m, 2H, cod-CH2). 13C{1H}
NMR (101 MHz, THF-d8): δ (ppm) 185.5 (C2), 142.2 (C4), 136.9
(C9), 129.0 (C6), 128.7 (C7), 115.6 (C5), 110.1 (C8), 74.4 (cod-
CH), 72.2 (cod-CH), 62.8 (cod-CH), 61.0 (cod-CH), 33.4 (C12),
33.0 (cod-CH2), 32.9 (cod-CH2), 32.8 (cod-CH2), 32.7 (cod-CH2),
20.3 (C11), 20.1 (C10). MS (MALDI-TOF, matrix DCTB) m/z: 918
[4]+.
1
mmol, 74%. H NMR (400 MHz, THF-d8): δ (ppm) 6.93 (s, 1H,
H5), 6.80 (s, 1H, H8), 3.93 (s, 3H, H12), 3.91 (m, 1H, cod-CH),
3.58 (m, 1H, cod-CH), 2.29 (m, 1H, cod-CH2), 2.22 (s, 3H, H11),
2.20 (s, 3H, H10), 2.05 (m, 1H, cod-CH2), 1.84 (m, 1H, cod-CH2),
1.72 (m, 1H, cod-CH2). 13C{1H} NMR (101 MHz, THF-d8): δ
(ppm) 192.6 (s, C2), 144.0 (s, C4), 134.6 (s, C9), 123.8 (C6), 123.1
(s, C7), 113.3 (s, C5), 105.6 (s, C8), 68.9 (s, cod-CH), 67.0 (s, cod-
CH), 30.3 (s, C112), 29.7 (s, cod-CH2), 29.4 (s, cod-CH2), 17.42 (s,
7
C11), 17.40 (s, C10). Li NMR (155 MHz, THF-d8): δ (ppm) 1.6.
MS (ESI, positive ions) m/z: 621.2566 [7−Li + 2H]+ (calcd for [7−
Li + 2H]+ 621.2570). MS (MALDI-TOF, matrix DCTB) m/z: 621
[7−Li + 2H]+.
4.7. Synthesis of Complex [6] from [7]. A sample of complex
[7] (27.7 mg, 0.04 mmol) was dissolved in THF (5 mL) and
[Rh(cod)(μ-Cl)]2 (10.8 mg, 0.02 mmol) was added as a solid. The
reaction mixture was stirred at ambient temperature for 12 h. The
solvent was removed in vacuo and the solid residue was washed with
methanol (2 × 5 mL) and dried under reduced pressure to give
complex [6] as a reddish solid. Yield: 29.9 mg, 0.036 mmol, 90%. 1H
NMR (400 MHz, THF-d8): δ (ppm) 7.38 (s, 1H, H5), 6.81 (s, 1H,
H8), 5.11−5.03 (m, 1H, cod-CH), 4.47−4.40 (m, 1H, cod-CH),
4.02−3.92 (m, 2H, cod-CH), 3.78 (s, 3H, H12), 2.87−2.81 (m, 1H,
cod-CH2), 2.62−2.55 (m, 2H, cod-CH2), 2.50−2.42 (m, 1H, cod-
CH2), 2.27 (s, 3H, H11), 2.21 (s, 3H, H10), 2.19−2.14 (m, 2H, cod-
CH2), 2.08−2.01 (m, 1H, cod-CH2), 1.99−1.93 (m, 1H, cod-CH2).
13C{1H} NMR (101 MHz, THF-d8): δ (ppm) 188.1 (s, C2), 143.4 (s,
C4), 137.1 (s, C9), 128.8 (s, C6), 128.2 (s, C7), 115.6 (s, C5), 109.9
4.4.2. Characterization of Complex [5]. Complex [5] was
1
obtained as an orange solid. Yield: 26 mg, 35 mmol, 35%. H NMR
(400 MHz, THF-d8): δ (ppm) 7.36 (s, 1H, H5), 6.77 (s, 1H, H8),
5.08 (s br, 1H, cod-CH), 4.79 (s br, 1H, cod-CH), 4.50 (s br, 1H,
cod-CH), 4.04 (s br, 1H, cod-CH), 3.82 (s, 3H, H12), 2.90−2.80 (m,
1H, cod-CH2), 2.78−2.71 (m, 1H, cod-CH2), 2.69−2.60 (m, 1H,
cod-CH2), 2.63−2.54 (m, 1H, cod-CH2), 2.37−2.29 (m, 2H, cod-
CH2), 2.25 (s, 3H, H11), 2.19 (s, 3H, H10), 2.08−2.02 (m, 1H, cod-
CH2), 2.02−1.95 (m, 1H, cod-CH2). 13C{1H} NMR (101 MHz,
1
THF-d8): δ (ppm) 192.5 (d, JCRh = 49.8 Hz, C2), 143.6 (s, C4),
1
1
136.5 (s, C9), 128.1 (s, C6), 127.6 (s, C7), 115.0 (s, C5), 109.2 (s,
(s, C8), 78.9 (d, JCRh = 3.9 Hz, cod-CH), 78.7 (d, JCRh = 2.6 Hz,
cod-CH), 73.6 (s, cod-CH), 72.1 (s, cod-CH), 33.24 (s, cod-CH2),
33.22 (s, C12), 32.8 (s, cod-CH2), 32.3 (s, cod-CH2), 32.0 (s, cod-
CH2), 20.5 (s C11), 20.2 (s, C10). MS (MALDI-TOF, matrix
DCTB) m/z: 831 [[6] + H]+.
1
1
C8), 87.2 (d, JCRh = 8.4 Hz, cod-CH), 86.6 (d, JCRh = 7.1 Hz, cod-
CH), 78.2 (d, 1JCRh = 10.2 Hz, cod-CH), 78.1 (d, 1JCRh = 8.9 Hz, cod-
CH), 33.4 (s, C12), 32.2 (s, 2 × cod-CH2), 31.9 (s, cod-CH2), 31.7
(s, cod-CH2), 20.3 (s, C11), 20.1 (s, C10). HRMS (ESI, positive
ions) m/z: 531.1989 [[5]−Rh(cod) + 2H]+ (calcd for [[5]−Rh(cod)
+ 2H]+ 531.1995).
4.8. General Procedure for the Synthesis of Complexes [8]
and [9]. Lithium diisopropylamide (16 mg, 0.15 mmol) was dissolved
in THF (4 mL) and the solution was cooled to −78 °C. The caffeine
(19.8 mg, 0.10 mmol) was added. The reaction mixture was stirred for
2 h at −78 °C. Subsequently, [Ir(cod)(μ-Cl)]2 (33.6 mg, 0.05 mmol)
or [Rh(cod)(μ-Cl)]2 (24.7 mg, 0.05 mmol) was added and the
solution was stirred for 12 h while it was allowed to warm up to
ambient temperature. The solvent was removed in vacuo and the solid
residue was washed with methanol (2 × 2 mL) and dried under
reduced pressure.
4.5. Synthesis of the Complex Mixture [4]−[6]. Compound 1
(32.0 mg, 0.20 mmol) was dissolved in THF (5 mL) and cooled to
−78 °C. Then, n-BuLi (0.2 mmol, 0.13 mL of a 1.6 M solution in n-
hexane) was added. The reaction mixture was stirred for 2 h at −78
°C. Subsequently, [Ir(cod)(μ-Cl)]2 (33.6 mg, 0.05 mmol) and
[Rh(cod)(μ-Cl)]2 (24.7 mg, 0.05 mmol) were added and the solution
was stirred for 12 h while it was allowed to warm up to ambient
temperature. The solvent was removed in vacuo and the resulting
residue was washed with methanol (2 × 5 mL) and dried under
reduced pressure. The mixture of complexes [4]−[6] was obtained as
4.8.1. Characterization of Complex [8]. Yield: 14 mg, 0.014
mmol, 28%, ratio [8H−H]/[8H−T] 50:50. H NMR (400 MHz, THF-
1
F
Organometallics XXXX, XXX, XXX−XXX